跳至主要内容
临床试验/NCT06290427
NCT06290427招募中不适用

Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney

Azienda Ospedaliera Universitaria Integrata Verona2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
2
主要终点
Number of participants with postoperative complications

研究概览

简要总结

The Urology Unit of AOUI Verona proposes a clinical study aimed at a preliminary evaluation of postoperative complications specifically focused on robotic partial nephrectomy (RAPN) procedures using two currently available platforms:

  • DaVinci®;
  • Hugo®.

The questions it aims to answer are:

Does the estimation of the post-operative complications suggest something? Are differences (intra- and post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable?

Participants will be invited to join one of these two experimental group:

  1. surgery with the DaVinci platform;
  2. surgery with the Hugo platform.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient aged between 18 and 90 years old;
  • patient with localized kidney tumor suitable for partial nephrectomy;
  • patient able to understand and sign the informed consent;
  • patient compliance with the follow-up program.

排除标准

  • patient who do not fall within the inclusion age range;
  • patient not suitable for partial nephrectomy;
  • patient unable to understand and sign the informed consent;
  • patient unable to follow the monitoring program;
  • patient refusal to participate to the study.

研究组 & 干预措施

DaVinci system

Active Comparator

Robot-assisted partial nephrectomy is performed using the DaVinci platform

干预措施: DaVinci RAPN (Device)

Hugo RAS system

Experimental

Robot-assisted partial nephrectomy is performed using the Hugo RAS platform

干预措施: Hugo RAS RAPN (Device)

结局指标

主要结局

Number of participants with postoperative complications

时间窗: Over the 4 days post surgery

Overall postoperative complications (% score \>0) are considered by Clavien-Dindo Classification 7 grades (I, II, IIIa, IIIb, IVa, IVb and V): the higher the grade, the higher the severity of the complication

Number of participants with moderate to major postoperative complications

时间窗: Over the 4 days post surgery

Moderate to major complications (% score \>=2) are considered by Clavien-Dindo Classification 7 grades (I, II, IIIa, IIIb, IVa, IVb and V): the higher the grade, the higher the severity of the complication

Number of participants with major postoperative complications

时间窗: Over the 4 days post surgery

Major complications (% score \>=3) are considered by Clavien-Dindo Classification 7 grades (I, II, IIIa, IIIb, IVa, IVb and V): the higher the grade, the higher the severity of the complication

次要结局

  • Number of intraoperative technical malfunctions(Intraoperative)
  • Estimated Blood Loss(Intraoperative)
  • Positive Surgical Margins(Up to 2 weeks postoperative (at the end of histological analysis))
  • Overall duration of the surgery(Intraoperative)
  • Type of intraoperative technical malfunctions(Intraoperative)
  • Number of intraoperative complications(Intraoperative)
  • Type of intraoperative complications(Intraoperative)
  • Postoperative hospitalization(From the day after surgery up to 10 days postoperative)
  • Postoperative pain(1-4 days postoperative)
  • Serum Creatinine dosage for renal function assessment(1 month, 3 and 6 months follow-up)
  • Estimated Glomerular Filtration Rate for renal function assessment(1 month, 3 and 6 months follow-up)
  • Procedure-related costs(From surgical procedure to the end of follow-up period (6 months))
  • Time taken for platform related timings(From the room setting, through the overall surgical procedure, until postoperative room restoration for each of expected 45 surgeries (through study completion: about 4 months))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alessandro Antonelli, MD, Prof

MD, Director of Urology Unit

Azienda Ospedaliera Universitaria Integrata Verona

研究点 (2)

Loading locations...

相似试验